PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
202.31%
Revenue growth above 1.5x 5715.T's 6.45%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
157.37%
Positive gross profit growth while 5715.T is negative. John Neff would see a clear operational edge over the competitor.
9397.65%
Positive EBIT growth while 5715.T is negative. John Neff might see a substantial edge in operational management.
6731.65%
Positive operating income growth while 5715.T is negative. John Neff might view this as a competitive edge in operations.
2551.92%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
2619.15%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2619.15%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.37%
Negative 10Y revenue/share CAGR while 5715.T stands at 72.06%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
232.45%
5Y revenue/share CAGR above 1.5x 5715.T's 7.83%. David Dodd would look for consistent product or market expansions fueling outperformance.
157.40%
3Y revenue/share CAGR above 1.5x 5715.T's 0.29%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
111.29%
Similar net income/share CAGR to 5715.T's 110.57%. Walter Schloss would see parallel tailwinds or expansions for both firms.
548.37%
Positive 5Y CAGR while 5715.T is negative. John Neff might view this as a strong mid-term relative advantage.
159.94%
Positive short-term CAGR while 5715.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-55.85%
Negative equity/share CAGR over 10 years while 5715.T stands at 90.75%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
60.52%
5Y equity/share CAGR at 75-90% of 5715.T's 69.53%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
36.36%
3Y equity/share CAGR above 1.5x 5715.T's 23.52%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.79%
AR growth well above 5715.T's 7.30%. Michael Burry fears inflated revenue or higher default risk in the near future.
-46.20%
Inventory is declining while 5715.T stands at 18.45%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-18.86%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
11.64%
Positive BV/share change while 5715.T is negative. John Neff sees a clear edge over a competitor losing equity.
-36.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
298.15%
R&D growth of 298.15% while 5715.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.55%
We expand SG&A while 5715.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41